As a part of a 2018 NETRF Pilot Award, Justin Annes, MD, PhD, Stanford University, studied the levels of an enzyme called PAM (short for Peptidylglycine α-amidating monooxygenase) in primary NET tissue specimens donated by 109 patients between 1992-2013. The retrospective analysis of these specimens showed that a novel test for an enzyme secreted by neuroendocrine cells may help predict the course and outcome of neuroendocrine cancers.

Read more.